SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-003990
Filing Date
2022-04-11
Accepted
2022-04-11 16:30:39
Documents
1
Period of Report
2022-04-07

Document Format Files

Seq Description Document Type Size
1 form4-04112022_040401.html 4  
1 form4-04112022_040401.xml 4 6497
  Complete submission text file 0001415889-22-003990.txt   7877
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Issuer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KINIKSA PHARMACEUTICALS CORP. 100 HAYDEN AVENUE LEXINGTON MA 02421
Business Address
Ragosa Mark (Reporting) CIK: 0001835458 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38492 | Film No.: 22819975